REFERENTIES: 1. Villarino AV, Kanno Y, Ferdinand JR, O’Shea JJ. J Immunol. 2015;194(1):21-27. 2. Wang KS, Zom E, Ritz J. Blood. 2001;97(12):3860-3866. 3. Coskun M, Salem M, Pedersen J, Nielsen OH. Pharmacol Res. 2013;76:1-8. 4. Bottos A, Gotthardt D, Gill JW, et al. Nat Commun. 2016;7:12258. 5. Gotthardt D, Sexl V. Front Immunol. 2017;7:694. 6. Schwartz DM, Kanno Y, Villarino A, Ward M, Gadina M, O’Shea JJ. Nat Rev Drug Discov. 2017;16(12):843-862. 7. Neurath MF. Nat Rev Immunol. 2014;14(5):329-342. 8. O’Shea JJ, Schwartz DM, Villarino AV, Gadina M, McInnes IB, Laurence A. Annu Rev Med. 2015;66:311-328. 9. Danese S, Argollo M, Le Berre C, Peyrin-Biroulet L. Gut. 2019;68(10):1893-1899. 10. Virtanen AT, Haikarainen T, Raivola J, Silvennoinen O. BioDrugs. 2019;33(1):15-32. 11. Pinto SM, Subbannayya Y, Rex DAB, et al. J Cell Commun Signal. 2018;12(3):615-624. 12. Salas A, Hernandez-Rocha C, Duijvestein M, et al. Nat Rev Gastroenterol Hepatol. 2020;17(6):323-337. 13. Flamant M, Rigaill J, Paul S, Roblin X. Drugs. 2017;77(10):1057-1068. 14. Fernández-Clotet A, Castro-Poceiro J, Panés J. Curr Pharm Des. 2019;25(1):32-40.
GALAPAGOS en het GALAPAGOS-logo zijn geregistreerde of aangevraagde handelsmerken van Galapagos NV.
© 2022 Galapagos NV. Alle rechten voorbehouden.
NL-NA-GLPG-202205-00004
© Copyright 2022 Galapagos NV